Your session is about to expire
← Back to Search
Veltassa for Hyperkalemia (PLATINUM Trial)
Phase 4
Waitlist Available
Research Sponsored by Comprehensive Research Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 hours after study drug dose is given
Awards & highlights
PLATINUM Trial Summary
This trial is testing a drug to see if it can lower potassium levels in people who come to the emergency room with high potassium.
PLATINUM Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 hours after study drug dose is given
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 hours after study drug dose is given
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The need for additional potassium-lowering medical interventions
Secondary outcome measures
Potassium level trends after receiving study drug
PLATINUM Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: VeltassaActive Control1 Intervention
3 packets of study drug powder will be mixed with a liquid (water, apple or cranberry juice) and given to patient to drink while in the emergency department
Group II: PlaceboPlacebo Group1 Intervention
3 packets of study drug powder will be mixed with a liquid (water, apple or cranberry juice) and given to patient to drink while in the emergency department
Find a Location
Who is running the clinical trial?
Comprehensive Research AssociatesLead Sponsor
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger